ALDX: Aldeyra Therapeutics Inc

ALDX新闻

• 14:37 SMMT Stock Soars on NSCLC Drug Survival Data Beating Keytruda in China
• 15:49 Krystal Stock Gains 13.4% in a Month: What Is Driving the Rally?
• 15:43 FDA Accepts UTHR's sNDA for Tyvaso in Idiopathic Pulmonary Fibrosis
• 15:25 RARE Stock Down 46% as Phase III Angelman Syndrome Study Misses Goals
• 15:01 Here's Why You Should Add RNTX Stock to Your Portfolio Now
• 13:20 AZN's Tagrisso Plus Orpathys Study in First-Line NSCLC Meets Goal
• 13:05 KURA Stock Gains 37.6% in a Month: Here's What You Need to Know
• 16:32 BNTX Ends Colorectal Cancer Immunotherapy Study, Stock Down
• 14:03 LLY's Mounjaro Gets FDA Nod to Cut Cardiovascular Risk in Diabetes
• 14:58 Here's Why You Should Add ARQT Stock to Your Portfolio Now
• 14:41 Gilead Wins FDA Nod for Bixlenvo in Adults Living With HIV Infection
• 20:45 Aldeyra Therapeutics: What Comes Next After Reproxalap's Third CRL (NASDAQ:ALDX)
• 09:59 Shareholders Sue Aldeyra Therapeutics Over Dry Eye Drug Claims - TipRanks.com
• 18:00 AbbVie: Buy Or Sell Ahead Of Q1 Earnings? It's A Buy, But With Caveats (Upgrade) (ABBV)
• 15:10 ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA
• 20:30 U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.10%
• 20:30 美国股市上涨；截至收盘道琼斯工业平均指数上涨0.10%
• 14:27 RBC因干眼症竞争对手延迟而重申Bausch & Lomb股票评级
• 14:25 RBC reiterates Bausch & Lomb stock rating on DED rival delay
• 13:16 FDA rejects Aldeyra’s dry eye disease drug application
• 14:40 Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?
• 14:55 Does Aldeyra Therapeutics (ALDX) Have the Potential to Rally 79.28% as Wall Street Analysts Expect?
• 16:15 根据BTIG分析的今年顶级医疗保健股票
• 16:14 Top Healthcare Stocks for This Year According to BTIG